Eli Lilly recently received approval for the multi-dose vial formulations of Zepbound (tirzepatide) and Mounjaro (tirzepatide)
Luo X, Hu Y, He S, Ye Q, Lv Z, Liu J, et al
Understanding what each agent is and what it is not is essential before drawing any meaningful comparison
Six cost drivers explain it, none related to the drug itself
Indeed, age-related declines in skeletal muscle mass index (SMI) and function often occur in parallel with increases in total FM, while the clinical course of obesity is characterized by a range of risk factors for sarcopenia, including elevated oxidative stress, inflammation, and the burden of NCDs [15, 16]